Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $24,885 - $33,711
-210 Reduced 10.0%
1,890 $230,000
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $379 - $705
-3 Reduced 0.14%
2,100 $362,000
Q4 2021

Feb 15, 2022

SELL
$225.82 - $368.51 $2,032 - $3,316
-9 Reduced 0.43%
2,103 $534,000
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $468,652 - $1.02 Million
2,112 New
2,112 $813,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Peapack Gladstone Financial Corp Portfolio

Follow Peapack Gladstone Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.